Clinical surveillance of thrombotic microangiopathies in Scotland, 2003–2005
- 5 March 2007
- journal article
- Published by Cambridge University Press (CUP) in Epidemiology and Infection
- Vol. 136 (1) , 115-121
- https://doi.org/10.1017/s0950268807008217
Abstract
The prevalence, incidence and outcomes of haemolytic uraemic syndrome (HUS) and thrombotic thrombocytopaenic purpura (TTP) are not well established in adults or children from prospective studies. We sought to identify both outcomes and current management strategies using prospective, national surveillance of HUS and TTP, from 2003 to 2005 inclusive. We also investigated the links between these disorders and factors implicated in the aetiology of HUS and TTP including infections, chemotherapy, and immunosuppression. Most cases of HUS were caused by verocytotoxin-producingEscherichia coli(VTEC), of which serotype O157 predominated, although other serotypes were identified. The list of predisposing factors for TTP was more varied although use of immunosuppressive agents and severe sepsis, were the most frequent precipitants. The study demonstrates that while differentiating between HUS and TTP is sometimes difficult, in most cases the two syndromes have quite different predisposing factors and clinical parameters, enabling clinical and epidemiological profiling for these disorders.Keywords
This publication has 24 references indexed in Scilit:
- Risk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking waterCMAJ : Canadian Medical Association Journal, 2005
- Relative Nephroprotection DuringEscherichia coliO157:H7 Infections: Association With Intravenous Volume ExpansionPediatrics, 2005
- Clopidogrel-Associated TTPStroke, 2004
- Recent Advances in Thrombotic Thrombocytopenic PurpuraHematology-American Society Hematology Education Program, 2004
- The Risk of the Hemolytic–Uremic Syndrome after Antibiotic Treatment ofEscherichia coliO157:H7 InfectionsNew England Journal of Medicine, 2000
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Long term renal outcome of childhood haemolytic uraemic syndrome.BMJ, 1991
- Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic SyndromeNew England Journal of Medicine, 1991
- Long-term outcome and prognostic indicators in the hemolytic-uremic syndromeThe Journal of Pediatrics, 1991
- HUS and TTP: Variable expression of a single entityKidney International, 1987